FDA 510(k) Clearances - August 2024

280 medical devices cleared by the FDA. Data sourced from the FDA 510(k) public files.

280
Cleared
17
Specialties
157d
Avg review

August 2024 overview

The FDA cleared 280 medical devices in August 2024 through the 510(k) premarket notification pathway. This compares to 247 clearances in July 2024 - an increase of 33 (+13.4%).

Orthopedic led all specialties with 43 cleared devices. The fastest average review was Hematology at 28 days. The slowest was Microbiology at 322 days.

Overall average review time: 157 days, ranging from 1 to 1056 days. The FDA's standard 510(k) review target is 90 days.

Clearances by specialty - August 2024

Detailed data

Review time in calendar days from FDA receipt to decision. Source: FDA 510(k) downloadable files.

Specialty Cleared Avg days Min Max vs July
Orthopedic 43 126 17 590 +10
General & Plastic Surgery 41 133 23 1056 -
Radiology 40 134 23 338 +9
Cardiovascular 24 151 17 300 +1
Dental 22 198 1 703 -4
General Hospital 21 116 26 270 +6
Neurology 17 185 22 382 +8
Gastroenterology & Urology 15 131 29 352 -4
Obstetrics & Gynecology 10 178 25 424 -
Anesthesiology 10 230 57 408 +3
Physical Medicine 10 176 62 311 +3
Microbiology 9 322 90 884 +3
Chemistry 8 203 32 760 -
Ophthalmic 6 248 30 613 +1
Toxicology 2 35 29 40 +1
Hematology 1 28 28 28 -
Immunology 1 171 171 171 -1
Total 280 157 1 1056 +33

Key observations

Fastest reviews

The fastest individual clearance took 1 day. Reviews under 5 days typically reflect Special 510(k) submissions for minor modifications to already-cleared devices.

Longest review

The longest individual review reached 1056 days. Extended reviews typically indicate additional information requests or complex predicate device questions. The FDA's standard target is 90 days from receipt.

Leading specialty: Orthopedic

Orthopedic led August 2024 with 43 clearances - 15% of all monthly clearances.

Review time spread

Microbiology posted the highest average at 322 days. Hematology was fastest at 28 days. The gap of 294 days between fastest and slowest specialties reflects differences in device complexity and regulatory pathway.

Most active manufacturers

The most active manufacturers in August 2024 were Fisher &Paykel Healthcare , Ltd. (3) , Biokit, S.A. (2) , Abbott Medical (2) , SurGenTec, LLC (2) and Siemens Medical Solutions USA, Inc. (2) . Together, these five manufacturers accounted for 11 of the 280 total clearances - 4% of all August activity.

About this data

This report covers FDA 510(k) submissions with a decision date in August 2024 and a valid days-to-decision value. Data is sourced from the FDA 510(k) public files, published on the 5th of each month and in the public domain (17 U.S.C. § 105). Only cleared decisions are counted (SESE, SESK, SESU, SEKD, SESP, SESD, ST, SN).

Maintained by Space Bits, S.L. Not affiliated with or endorsed by the FDA. Verify at accessdata.fda.gov.